Default: Current Opinion in Pharmacology

ISSN: 1471-4892

Journal Home

Journal Guideline

Current Opinion in Pharmacology Q1 Unclaimed

Elsevier BV Netherlands
Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Current Opinion in Pharmacology is a journal indexed in SJR in Drug Discovery and Pharmacology with an H index of 132. It has an SJR impact factor of 1,868 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 1,868.

Current Opinion in Pharmacology focuses its scope in these topics and keywords: cancer, cardiovascular, lung, cell, therapeutic, current, development, diabeteseditorial, critically, genesdelineation, ...

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy: Open Choice

Type of publications:

Publication frecuency: -

Price

- €

Inmediate OA

NPD

Embargoed OA

- €

Non OA

Metrics

Current Opinion in Pharmacology

1,868

SJR Impact factor

132

H Index

109

Total Docs (Last Year)

343

Total Docs (3 years)

6638

Total Refs

1728

Total Cites (3 years)

306

Citable Docs (3 years)

4,81

Cites/Doc (2 years)

60,90

Ref/Doc

Aims and Scope


cancer, cardiovascular, lung, cell, therapeutic, current, development, diabeteseditorial, critically, genesdelineation, definition, diseasesregulation, dose, encapsulation, enzyme, essentials, etiology, facilitates, foreign, concepts, complications, approachesinsulin, augmented, axisadvances, bacteria, betalactam, biomarkers, blood, body, canceradenoassociated, challenges, channels, checkpoints, cholesterol, clearance,



Best articles by citations

Pharmacology

View more

Pharmacology

View more

'Omic' and hypothesis-driven research in the molecular pharmacology of cancer

View more

Cancer Immunomodulation

View more

Serotonergic targets in depression

View more

Paper alert: Pharmacology

View more

Paper alert: Pharmacology

View more

Inflammatory markers and coronary artery disease

View more

Nucleic acid and polypeptide aptamers: a powerful approach to ligand discovery

View more

Gonadotropin-releasing hormone antagonists

View more

Cellular screening assays using fluorescence microscopy

View more

Proteomics: an holistic analysis of nature's proteins

View more
SHOW MORE ARTICLES

Hepatorenal syndrome: pathogenesis and novel pharmacological targets

View more

Gastric leptin: a new manager of gastrointestinal function

View more

Metabotropic glutamate 2/3 receptors as drug targets

View more

Reporter-gene systems for the study of G-protein-coupled receptors

View more

Inhibition of IL-6 for the treatment of inflammatory diseases

View more

Somatostatin analogs - from new molecules to new applications

View more

Oligomerization of opioid receptors: generation of novel signaling units

View more

Anti-inflammatory therapy for heart failure

View more

Calcium channels in enteric neurons

View more

Neuroimmunophilin ligands in the treatment of Parkinson's disease

View more

Neurosciences

View more

Estrogens in postmenopausal women: recent insights

View more

Comments

No comments ... Be the first to comment!

FAQS